Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Redlich

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Nature Reviews. Drug Discovery|March 2, 2012
Inflammatory bone loss: pathogenesis and therapeutic interventionKurt Redlich, Josef S Smolen
Arthritis Research & Therapy|August 23, 2003
The role of osteoprotegerin in arthritisGeorg Schett, Kurt Redlich, Josef S Smolen
Immunity|April 11, 2008
Cytokines as therapeutic targets: advances and limitationsClemens Scheinecker, Kurt Redlich, Josef S Smolen
Seminars in Immunopathology|September 13, 2014
Mechanisms of tissue damage in arthritisStephan Blüml, Kurt Redlich, Josef S Smolen
Nature Reviews. Rheumatology|March 14, 2012
The pathogenesis of rheumatoid arthritis: new insights from old clinical data?Josef S Smolen, Daniel Aletaha, Kurt Redlich
Annals of the New York Academy of Sciences|August 30, 2005
Pathogenesis of rheumatoid arthritis: targeting cytokinesJochen Zwerina, Kurt Redlich, Georg Schett, et al.
International Immunology|March 30, 2012
Targeting TNF receptors in rheumatoid arthritisStephan Blüml, Clemens Scheinecker, Josef S Smolen, et al.
Annals of the Rheumatic Diseases|May 26, 2010
Interleukin 6 is not a crucial regulator in an animal model of tumour necrosis factor-mediated bilateral sacroiliitisSilvia Hayer, Birgit Niederreiter, Ionela Nagelreiter, et al.
Arthritis Research & Therapy|March 2, 2006
Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritisJochen Zwerina, Birgit Tuerk, Kurt Redlich, et al.
Nature Clinical Practice. Rheumatology|August 26, 2006
Mechanisms of Disease: the link between RANKL and arthritic bone diseaseGeorg Schett, Silvia Hayer, Jochen Zwerina, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Nature Reviews. Drug Discovery|March 2, 2012
Inflammatory bone loss: pathogenesis and therapeutic interventionKurt Redlich, Josef S Smolen
Arthritis Research & Therapy|August 23, 2003
The role of osteoprotegerin in arthritisGeorg Schett, Kurt Redlich, Josef S Smolen
Immunity|April 11, 2008
Cytokines as therapeutic targets: advances and limitationsClemens Scheinecker, Kurt Redlich, Josef S Smolen
Seminars in Immunopathology|September 13, 2014
Mechanisms of tissue damage in arthritisStephan Blüml, Kurt Redlich, Josef S Smolen
Nature Reviews. Rheumatology|March 14, 2012
The pathogenesis of rheumatoid arthritis: new insights from old clinical data?Josef S Smolen, Daniel Aletaha, Kurt Redlich
Annals of the New York Academy of Sciences|August 30, 2005
Pathogenesis of rheumatoid arthritis: targeting cytokinesJochen Zwerina, Kurt Redlich, Georg Schett, et al.
International Immunology|March 30, 2012
Targeting TNF receptors in rheumatoid arthritisStephan Blüml, Clemens Scheinecker, Josef S Smolen, et al.
Annals of the Rheumatic Diseases|May 26, 2010
Interleukin 6 is not a crucial regulator in an animal model of tumour necrosis factor-mediated bilateral sacroiliitisSilvia Hayer, Birgit Niederreiter, Ionela Nagelreiter, et al.
Arthritis Research & Therapy|March 2, 2006
Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritisJochen Zwerina, Birgit Tuerk, Kurt Redlich, et al.
Nature Clinical Practice. Rheumatology|August 26, 2006
Mechanisms of Disease: the link between RANKL and arthritic bone diseaseGeorg Schett, Silvia Hayer, Jochen Zwerina, et al.
Pageof 7